Alkem signs agreement with US-based Sonnet BioTherapeutics to develop, commercialise its drug candidate for diabetic peripheral neuropathy in India Read more
Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India Read more
Alkem MedTech signs agreement with Exactech to manufacture and market knee and hip replacement implants in India Read more